4 – Alzheimers

Britain’s healthcare cost agency plans to end controversial restrictions on Alzheimer’s drugs in a policy U-turn that could give hundreds of thousands of patients access to previously denied medicines.

Continued here:
UK cost agency to end curbs on Alzheimer’s ... continue reading